The pooled HRs revealed a significant association between iNOS overexpression and unfavorable prognosis in gastric cancer (HR: 2.17; 95% CI: 1.60 - 2.95, p ≤ 0.001; fixed-effect) (Figure 3). This evidence concerns the gene NOS2 and gastric cancer.